| 0M6 | 表記: | N-[(2S)-1,4-dihydroxybutan-2-yl]-N~2~-(phenylcarbamothioyl)-L-leucinamide | 組成式: | C17 H27 N3 O3 S | SMILES: | S=C(Nc1ccccc1)NC(C(=O)NC(CCO)CO)CC(C)C | InChi: | InChI=1S/C17H27N3O3S/c1-12(2)10-15(16(23)18-14(11-22)8-9-21)20-17(24)19-13-6-4-3-5-7-13/h3-7,12,14-15,21-22H,8-11H2,1-2H3,(H,18,23)(H2,19,20,24)/t14-,15-/m0/s1 | 別名: | SNJ-1715, bound form | 定義日: | 2012-02-28 | 最終更新日: | 2024-09-27 | 識別子(ID): | N-[(2S)-1,4-dihydroxybutan-2-yl]-N~2~-(phenylcarbamothioyl)-L-leucinamide |
|
| INP | 表記: | 4-[[N-[(PHENYLMETHOXY)CARBONYL]-/NL/N-LEUCYL]AMINO]-1[(2S)-2-[[[4-(PYRIDINYLMETHOXY)CARBONYL]AMINO]-4-METHYLPENT/NYL]-3-PYRROLIDINONE/N | 組成式: | C31 H43 N5 O6 | SMILES: | O=C(OCc1ccncc1)NC(C(=O)NC3C(=O)CN(CC(NC(=O)OCc2ccccc2)CC(C)C)C3)CC(C)C | InChi: | InChI=1S/C31H43N5O6/c1-21(2)14-25(33-30(39)41-19-23-8-6-5-7-9-23)16-36-17-27(28(37)18-36)34-29(38)26(15-22(3)4)35-31(40)42-20-24-10-12-32-13-11-24/h5-13,21-22,25-27H,14-20H2,1-4H3,(H,33,39)(H,34,38)(H,35,40)/t25-,26-,27+/m0/s1 | 別名: | PYRROLIDINONE | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | N-{(3R)-1-[(2S)-2-{[(benzyloxy)carbonyl]amino}-4-methylpentyl]-4-oxopyrrolidin-3-yl}-N~2~-[(pyridin-4-ylmethoxy)carbonyl]-L-leucinamide |
|
| HSK | 表記: | 3-hydroxy-L-histidine | 組成式: | C6 H9 N3 O3 | SMILES: | O=C(O)C(N)Cc1cncn1O | InChi: | InChI=1S/C6H9N3O3/c7-5(6(10)11)1-4-2-8-3-9(4)12/h2-3,5,12H,1,7H2,(H,10,11)/t5-/m0/s1 | 定義日: | 2014-05-01 | 最終更新日: | 2024-09-27 | 公開日: | 2014-09-03 | 識別子(ID): | 3-hydroxy-L-histidine |
|
| INS | 表記: | 1,2,3,4,5,6-HEXAHYDROXY-CYCLOHEXANE | 組成式: | C6 H12 O6 | SMILES: | OC1C(O)C(O)C(O)C(O)C1O | InChi: | InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3-,4+,5-,6- | 別名: | MYO-INOSITOL | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | (1R,2S,3r,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol |
|
| HSO | 表記: | L-histidinol | 組成式: | C6 H12 N3 O | SMILES: | NC(CO)Cc1[nH+]cnc1 | InChi: | InChI=1S/C6H11N3O/c7-5(3-10)1-6-2-8-4-9-6/h2,4-5,10H,1,3,7H2,(H,8,9)/p+1/t5-/m0/s1 | 定義日: | 1999-07-08 | 最終更新日: | 2024-09-27 | 識別子(ID): | 4-[(2S)-2-amino-3-hydroxypropyl]-1H-imidazol-3-ium |
|
| HSQ | 表記: | 2-acetylamino-2-deoxy-alpha-L-idopyranose | 組成式: | C8 H15 N O6 | SMILES: | O=C(NC1C(O)C(O)C(OC1O)CO)C | InChi: | InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5+,6+,7+,8+/m0/s1 | 別名: | N-acetyl-alpha-L-idosamine | 定義日: | 2009-01-16 | 最終更新日: | 2024-09-27 | 識別子(ID): | 2-(acetylamino)-2-deoxy-alpha-L-idopyranose |
|
| YGX | 表記: | (1~{S},2~{S},4~{S},5~{R})-6-(hydroxymethyl)cyclohexane-1,2,3,4,5-pentol | 組成式: | C7 H14 O6 | SMILES: | OC[CH]1[CH](O)[CH](O)[CH](O)[CH](O)[CH]1O | InChi: | InChI=1S/C7H14O6/c8-1-2-3(9)5(11)7(13)6(12)4(2)10/h2-13H,1H2/t2-,3+,4-,5-,6-,7-/m0/s1 | 定義日: | 2023-06-15 | 最終更新日: | 2024-09-27 | 公開日: | 2023-10-04 | 識別子(ID): | (1~{S},2~{S},4~{S},5~{R})-6-(hydroxymethyl)cyclohexane-1,2,3,4,5-pentol |
|
| 0MG | 表記: | amino{[(4S)-4-amino-5-carboxy-5-oxopentyl]amino}methaniminium | 組成式: | C7 H15 N4 O3 | SMILES: | O=C(C(=O)O)C(N)CCCNC(=[NH2+])N | InChi: | InChI=1S/C7H14N4O3/c8-4(5(12)6(13)14)2-1-3-11-7(9)10/h4H,1-3,8H2,(H,13,14)(H4,9,10,11)/p+1/t4-/m0/s1 | 定義日: | 2010-09-24 | 最終更新日: | 2024-09-27 | 識別子(ID): | amino{[(4S)-4-amino-5-carboxy-5-oxopentyl]amino}methaniminium |
|
| HSV | 表記: | L-histidinal | 組成式: | C6 H10 N3 O | SMILES: | NC(C=O)Cc1[nH+]cnc1 | InChi: | InChI=1S/C6H9N3O/c7-5(3-10)1-6-2-8-4-9-6/h2-5H,1,7H2,(H,8,9)/p+1/t5-/m0/s1 | 定義日: | 2015-06-17 | 最終更新日: | 2024-09-27 | 識別子(ID): | 4-[(2S)-2-amino-3-oxopropyl]-1H-imidazol-3-ium |
|
| HSX | 表記: | 5-O-phosphono-alpha-D-ribofuranose | 組成式: | C5 H11 O8 P | SMILES: | O=P(O)(O)OCC1OC(O)C(O)C1O | InChi: | InChI=1S/C5H11O8P/c6-3-2(1-12-14(9,10)11)13-5(8)4(3)7/h2-8H,1H2,(H2,9,10,11)/t2-,3-,4-,5+/m1/s1 | 別名: | 5-O-phosphono-alpha-D-ribose | 定義日: | 2009-01-16 | 最終更新日: | 2024-09-27 | 識別子(ID): | 5-O-phosphono-alpha-D-ribofuranose |
|
| HSY | 表記: | alpha-L-xylopyranose | 組成式: | C5 H10 O5 | SMILES: | OC1C(O)COC(O)C1O | InChi: | InChI=1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3+,4-,5+/m0/s1 | 別名: | alpha-L-xylose | 定義日: | 2009-01-16 | 最終更新日: | 2024-09-27 | 識別子(ID): | alpha-L-xylopyranose |
|
| HT0 | 表記: | (4R,5R)-5-(4-hydroxyphenyl)-2-oxo-1,3-oxazolidine-4-carboxylic acid | 組成式: | C10 H9 N O5 | SMILES: | O=C(O)C1NC(=O)OC1c1ccc(O)cc1 | InChi: | InChI=1S/C10H9NO5/c12-6-3-1-5(2-4-6)8-7(9(13)14)11-10(15)16-8/h1-4,7-8,12H,(H,11,15)(H,13,14)/t7-,8-/m1/s1 | 定義日: | 2021-03-10 | 最終更新日: | 2024-09-27 | 公開日: | 2022-12-07 | 識別子(ID): | (4R,5R)-5-(4-hydroxyphenyl)-2-oxo-1,3-oxazolidine-4-carboxylic acid |
|
| YHA | 表記: | Homocitrulline | 組成式: | C7 H15 N3 O3 | SMILES: | NC(CCCCNC(N)=O)C(=O)O | InChi: | InChI=1S/C7H15N3O3/c8-5(6(11)12)3-1-2-4-10-7(9)13/h5H,1-4,8H2,(H,11,12)(H3,9,10,13)/t5-/m0/s1 | 別名: | N~6~-carbamoyl-L-lysine | 定義日: | 2021-03-04 | 最終更新日: | 2024-09-27 | 公開日: | 2022-05-25 | 識別子(ID): | N~6~-carbamoyl-L-lysine |
|
| IO8 | 表記: | 2-[2-(aminomethyl)-4-(1H-indol-3-ylmethyl)-5-oxidanylidene-4H-imidazol-1-yl]ethanoic acid | 組成式: | C15 H14 N4 O3 | SMILES: | NCC1=NC(=Cc2c[nH]c3ccccc23)C(=O)N1CC(O)=O | InChi: | InChI=1S/C15H14N4O3/c16-6-13-18-12(15(22)19(13)8-14(20)21)5-9-7-17-11-4-2-1-3-10(9)11/h1-5,7,17H,6,8,16H2,(H,20,21)/b12-5- | 別名: | CHROMOPHORE (GLY-TRP-GLY) | 定義日: | 2022-04-01 | 最終更新日: | 2024-09-27 | 公開日: | 2022-05-04 | 識別子(ID): | 2-[(4~{Z})-2-(aminomethyl)-4-(1~{H}-indol-3-ylmethylidene)-5-oxidanylidene-imidazol-1-yl]ethanoic acid |
|
| YHD | 表記: | N-[(1R)-2-([1,1'-biphenyl]-4-yl)-1-boronoethyl]-1-methyl-L-prolinamide | 組成式: | C20 H25 B N2 O3 | SMILES: | O=C(NC(Cc1ccc(cc1)c1ccccc1)B(O)O)C1CCCN1C | InChi: | InChI=1S/C20H25BN2O3/c1-23-13-5-8-18(23)20(24)22-19(21(25)26)14-15-9-11-17(12-10-15)16-6-3-2-4-7-16/h2-4,6-7,9-12,18-19,25-26H,5,8,13-14H2,1H3,(H,22,24)/t18-,19-/m0/s1 | 定義日: | 2021-03-08 | 最終更新日: | 2024-09-27 | 公開日: | 2021-09-22 | 識別子(ID): | N-[(1R)-2-([1,1'-biphenyl]-4-yl)-1-boronoethyl]-1-methyl-L-prolinamide |
|
| HT7 | 表記: | (3S)-3-AMINO-4-(1H-INDOL-3-YL)BUTANOIC ACID | 組成式: | C12 H14 N2 O2 | SMILES: | O=C(O)CC(N)Cc2c1ccccc1nc2 | InChi: | InChI=1S/C12H14N2O2/c13-9(6-12(15)16)5-8-7-14-11-4-2-1-3-10(8)11/h1-4,7,9,14H,5-6,13H2,(H,15,16)/t9-/m0/s1 | 別名: | BETA-HOMOTRYPTOPHAN | 定義日: | 2011-05-18 | 最終更新日: | 2024-09-27 | 識別子(ID): | (3S)-3-amino-4-(1H-indol-3-yl)butanoic acid |
|
| 0MU | 表記: | (2R)-5-(acetyloxymethyl)-2-[(1R)-1-[[(5R)-5-azanyl-6-oxidanyl-6-oxidanylidene-hexanoyl]amino]-2-oxidanylidene-ethyl]-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid | 組成式: | C16 H23 N3 O8 S | SMILES: | CC(=O)OC[CH]1CS[CH](N=C1C(O)=O)[CH](NC(=O)CCC[CH](N)C(O)=O)C=O | InChi: | InChI=1S/C16H23N3O8S/c1-8(21)27-6-9-7-28-14(19-13(9)16(25)26)11(5-20)18-12(22)4-2-3-10(17)15(23)24/h5,9-11,14H,2-4,6-7,17H2,1H3,(H,18,22)(H,23,24)(H,25,26)/t9-,10+,11+,14+/m0/s1 | 別名: | CEPHALOSPORIN C, bound form | 定義日: | 2012-03-05 | 最終更新日: | 2024-09-27 | 公開日: | 2017-07-12 | 識別子(ID): | (2R)-5-(acetyloxymethyl)-2-[(1R)-1-[[(5R)-5-azanyl-6-oxidanyl-6-oxidanylidene-hexanoyl]amino]-2-oxidanylidene-ethyl]-5,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
|
| YHI | 表記: | benzyl (1R,2S,5S)-2-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate | 組成式: | C23 H31 N3 O5 | SMILES: | O=C1NCCC1CC(CO)NC(=O)C1C2C(CN1C(=O)OCc1ccccc1)C2(C)C | InChi: | InChI=1S/C23H31N3O5/c1-23(2)17-11-26(22(30)31-13-14-6-4-3-5-7-14)19(18(17)23)21(29)25-16(12-27)10-15-8-9-24-20(15)28/h3-7,15-19,27H,8-13H2,1-2H3,(H,24,28)(H,25,29)/t15-,16-,17-,18-,19-/m0/s1 | 定義日: | 2021-03-08 | 最終更新日: | 2024-09-27 | 公開日: | 2021-03-17 | 識別子(ID): | benzyl (1R,2S,5S)-2-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-3-carboxylate |
|
| YHJ | 表記: | benzyl (1S,3aR,6aS)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)hexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate | 組成式: | C23 H31 N3 O5 | SMILES: | O=C1NCCC1CC(CO)NC(=O)C1C2CCCC2CN1C(=O)OCc1ccccc1 | InChi: | InChI=1S/C23H31N3O5/c27-13-18(11-16-9-10-24-21(16)28)25-22(29)20-19-8-4-7-17(19)12-26(20)23(30)31-14-15-5-2-1-3-6-15/h1-3,5-6,16-20,27H,4,7-14H2,(H,24,28)(H,25,29)/t16-,17-,18-,19-,20-/m0/s1 | 定義日: | 2021-03-08 | 最終更新日: | 2024-09-27 | 公開日: | 2021-03-17 | 識別子(ID): | benzyl (1S,3aR,6aS)-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}carbamoyl)hexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate |
|
| 0N3 | 表記: | 3-({[(dihydroxyboranyl)methyl]sulfamoyl}methyl)benzoic acid | 組成式: | C9 H12 B N O6 S | SMILES: | O=S(=O)(NCB(O)O)Cc1cccc(c1)C(=O)O | InChi: | InChI=1S/C9H12BNO6S/c12-9(13)8-3-1-2-7(4-8)5-18(16,17)11-6-10(14)15/h1-4,11,14-15H,5-6H2,(H,12,13) | 定義日: | 2012-03-13 | 最終更新日: | 2024-09-27 | 公開日: | 2012-09-21 | 識別子(ID): | 3-({[(dihydroxyboranyl)methyl]sulfamoyl}methyl)benzoic acid |
|
| 0N4 | 表記: | [({[4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid | 組成式: | C8 H10 B N5 O4 S | SMILES: | O=S(=O)(c2ccc(c1nnnn1)cc2)NCB(O)O | InChi: | InChI=1S/C8H10BN5O4S/c15-9(16)5-10-19(17,18)7-3-1-6(2-4-7)8-11-13-14-12-8/h1-4,10,15-16H,5H2,(H,11,12,13,14) | 定義日: | 2012-03-13 | 最終更新日: | 2024-09-27 | 公開日: | 2012-09-21 | 識別子(ID): | [({[4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid |
|
| 0NA | 表記: | [({[6-(1H-tetrazol-5-yl)pyridin-3-yl]sulfonyl}amino)methyl]boronic acid | 組成式: | C7 H9 B N6 O4 S | SMILES: | O=S(=O)(c2cnc(c1nnnn1)cc2)NCB(O)O | InChi: | InChI=1S/C7H9BN6O4S/c15-8(16)4-10-19(17,18)5-1-2-6(9-3-5)7-11-13-14-12-7/h1-3,10,15-16H,4H2,(H,11,12,13,14) | 定義日: | 2012-03-16 | 最終更新日: | 2024-09-27 | 公開日: | 2012-09-21 | 識別子(ID): | [({[6-(1H-tetrazol-5-yl)pyridin-3-yl]sulfonyl}amino)methyl]boronic acid |
|
| 0NB | 表記: | [({[3-chloro-4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid | 組成式: | C8 H9 B Cl N5 O4 S | SMILES: | O=S(=O)(c2cc(Cl)c(c1nnnn1)cc2)NCB(O)O | InChi: | InChI=1S/C8H9BClN5O4S/c10-7-3-5(20(18,19)11-4-9(16)17)1-2-6(7)8-12-14-15-13-8/h1-3,11,16-17H,4H2,(H,12,13,14,15) | 定義日: | 2012-03-16 | 最終更新日: | 2024-09-27 | 公開日: | 2012-09-21 | 識別子(ID): | [({[3-chloro-4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid |
|
| 0NC | 表記: | N-methyl-L-alaninamide | 組成式: | C4 H10 N2 O | SMILES: | O=C(NC)C(N)C | InChi: | InChI=1S/C4H10N2O/c1-3(5)4(7)6-2/h3H,5H2,1-2H3,(H,6,7)/t3-/m0/s1 | 定義日: | 2008-03-31 | 最終更新日: | 2024-09-27 | 識別子(ID): | N-methyl-L-alaninamide |
|
| 0ND | 表記: | [({[2-chloro-4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid | 組成式: | C8 H9 B Cl N5 O4 S | SMILES: | O=S(=O)(c2c(Cl)cc(c1nnnn1)cc2)NCB(O)O | InChi: | InChI=1S/C8H9BClN5O4S/c10-6-3-5(8-12-14-15-13-8)1-2-7(6)20(18,19)11-4-9(16)17/h1-3,11,16-17H,4H2,(H,12,13,14,15) | 定義日: | 2012-03-16 | 最終更新日: | 2024-09-27 | 公開日: | 2012-09-21 | 識別子(ID): | [({[2-chloro-4-(1H-tetrazol-5-yl)phenyl]sulfonyl}amino)methyl]boronic acid |
|